TheEdgeResearch
Home / Stocks / PCLOF

PharmaCielo Ltd. (PCLOF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.03 ▼ -11.43%
Market Cap
$6.2M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
1.06
52-Wk Range
0.0037-0.117
CEO
Marc Lustig
Country
CA
Currency
USD

PharmaCielo Ltd. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Toronto, ON, CA. The stock last traded at $0.03, down 11.43% on the session, giving a market capitalisation of $6.2M. On trailing twelve-month figures it carries a trailing P/E of -1.87, a net margin of -103.1%. Its beta of 1.06 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-1.87
Price / Sales
1.94
Price / Book
-0.68
EV / EBITDA
-79.19
Gross margin
37.2%
Operating margin
-82.0%
Net margin
-103.1%
Return on equity
—
Debt / equity
-1.70
Current ratio
0.14
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
268
IPO date
2019-01-25
Headquarters
Toronto, ON, CA
About PharmaCielo Ltd.

PharmaCielo Ltd., operating in conjunction with its subsidiary, is primarily engaged in the comprehensive cultivation, processing, and distribution of pharmaceutical-grade cannabis extracts, including tetrahydrocannabinol (THC), and associated medicinal products. Additionally, the company diversifies its offerings by providing telemedicine software. Its clientele spans a range of entities, such as health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies, across both Canada and Colombia. PharmaCielo also holds a strategic partnership with AssuredTrans Inc., and its corporate headquarters are situated in Toronto, Canada.

Comparable companies

PharmaCielo Ltd. is most often compared with the following Healthcare names:

AUSAFAVTBFBBRRFBUDZCANNCPIVFIONKFLOBEFTHCBFVDQSF
More research on PCLOF
PCLOF technical analysis PCLOF TheEdge Score Compare against peers
Open full interactive analysis & DCF →